Presentation to Investors December 2014 4 October 20164 December 2014 by Justine Bednorz Presentation to Investors December 2014
Biotron Completes Enrolment in Phase 2 Hepatits C Trial of BIT225 3 December 20143 December 2014 by Justine Bednorz Biotron Completes Enrolment in Phase 2 Hepatitis C Trial of BIT225
Presentation to Annual General Meeting 4 October 201613 November 2014 by Justine Bednorz Presentation to Annual General Meeting
Results of Annual General Meeting 13 November 2014 by Justine Bednorz Results of Annual General Meeting
Presentation to Annual General Meeting 13 November 2014 by Justine Bednorz Presentation to Annual General Meeting
Fully Underwritten $4.06 Million Rights Issue Closes Oversubscribed 5 November 2014 by Justine Bednorz Fully Underwritten $4.06 Million Rights Issue Closes Oversubscribed